Jacob Zatuchni, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editors: Falk and Leavitt (1) would like to sound the death knell for digoxin as therapy for atrial fibrillation. They cannot understand why the drug has been popular for 200 years and conclude that it must be because of mythology and not science. Although aware of the beneficial effects of digoxin in patients with atrial fibrillation, they choose to emphasize its questionable use for prevention of atrial fibrillation in patients who have reverted to sinus rhythm, the possibility that digoxin makes recurrences of atrial fibrillation worse, and the questionable significance of tachycardia during exercise if it occurs. They
Zatuchni J. Requiem for Digoxin?. Ann Intern Med. 1991;114:993. doi: 10.7326/0003-4819-114-11-993_2
Download citation file:
Published: Ann Intern Med. 1991;114(11):993.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use